PERCEPTION OF CVD RISK FACTORS BY DIFFERENT STAKEHOLDERS - DOCTORS, MEDICAL STUDENTS, GENERAL PUBLIC, POLITICIANS, JOURNALISTS Professor ŽeljkoReiner,

Similar documents
Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).

Supplementary Online Content

ESC/EAS GUIDELINES ON MANAGEMENT OF DYSLIPIDEMIAS IN CLINICAL PRACTICE

ESC/EAS Guidelines for the Management of Dyslipidaemias

Deprivation Study. The Freiburg Study

To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees.

Cardiovascular Risk Assessment and Management Making a Difference

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up

Know Your Number Aggregate Report Single Analysis Compared to National Averages

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

BEST PRACTICE MANAGEMENT: CARDIOVASCULAR RISKS

ESPEN Congress Florence 2008

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

National Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register

Obesity Prevention and Control: Provider Education with Patient Intervention

Director, Employee Health & Productivity. Coordinator, Employee Health & Productivity

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic

2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE

Plasma Lipids and Global Cardiovascular Risk

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms

Risk Factors for Heart Disease

Cardiovascular Disease Risk Behaviors of Nursing Students in Nursing School

Croatian National Action Network Bone and Joint Decade A 10-YEAR REPORT

Diabetes Passport. East Coast Area Diabetes Integrated Care

Depok-Indonesia STEPS Survey 2003

EuroPRevent Risk assessment models: what is to come? Risk Assessment Models: Applications in Clinical Practice

CVD Prevention, Who to Consider

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Metabolic Syndrome in Asians

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

Disclosures. Objectives. Cardiovascular Risk. Patient Case. JUPITER: The final frontier in statin utilization or an idea from outer space?

Patient is healthy with no chronic disease or significant risk factors [16%].

ASSeSSing the risk of fatal cardiovascular disease

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION

PLEASE REMEMBER TO BRING TO EACH APPOINTMENT

Prof Rob Doughty Heart Foundation Chair Heart Health University of Auckland. Dr Fraser Hamilton. General Practitioner Heart Foundation Hamilton

WIN QUARTERLY UTILIZATION REPORT 7/1/2010 TO 12/31/2010. EXPERTISE PARTNERSHIP V A L U E April 20, 2011

Adult Pre Participation Screening and Exercise Prescription Practicum

Mississippi Stroke Systems of Care

Controversies in Preventative Cardiology

Diabetes Mellitus: A Cardiovascular Disease

Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups

DIABETES. A growing problem

Corporate Health Screening

CARE PATHWAYS. Allyson Ashley

Guidelines on cardiovascular risk assessment and management

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Prevention in Europe

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009

THE EFFECT OF SECONDHAND SMOKE EXPOSURE ON HIGH MOLECULAR WEIGHT ADIPONECTIN LEVELS IN ADULT WOMEN: A PRELIMINARY REPORT

290 Biomed Environ Sci, 2016; 29(4):

Case Study: Chris Arden. Peripheral Arterial Disease

John s Labs & Tests (for December 1, 2012)

Health First. New Health Bucks Program MANATEE YOURCHOICE HEALTH PLAN

Page 1. Disclosures. Background. No disclosures

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

ORIGINAL ARTICLE. Abstract. Introduction

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

Correspondence should be addressed to Peng-Fei Shan;

Clinical Care Performance. Financial Year 2012 to 2018

Regional of national clinical data. Do they help me to improve my practice? Rob Dijkstra, GP Dutch College of General Practitioners

well-targeted primary prevention of cardiovascular disease: an underused high-value intervention?

Discussion points. The cardiometabolic connection. Cardiometabolic Risk Management in the Primary Care Setting

Nutrition Care Process. Catherine Villafranca & Anthony Richitt

ABSTRACT: 9 DOES SOY CONSUMPTION HAVE AN EFFECT ON HYPERTENSION IN LOW-INCOME RURAL SOUTH AFRICAN WOMEN?

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Identification of subjects at high risk for cardiovascular disease

Put your Heart before your Head

30% of patients with T2D have high levels of urine albumin at diagnosis: 75% MAU 25% overt diabetic nephropathy

Dr Anne King dc life dclife.co.uk

Why are NICE guidelines and standards important and relevant to us?

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

6/10/2016. Hui-Chun Hsu

Effect of Combined Interventions of Diet and Physical Activity on the Perceived and Actual Risk of Coronary

Heart Age and Cardiovascular Risk

Evaluation of ischemia-modified albumin levels and parametersof arterial stiffness in patients with hypothyroidism

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Trends In CVD, Related Risk Factors, Prevention and Control In China

Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures

HEART RATE IN PATIENTS WITH CORONARY ARTERY DISEASE IN LATVIA

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Patient Education. intermountainhealthcare.org/diabetes. BG Tracker. for people with diabetes MONITORING BLOOD GLUCOSE

Abstract. Research Methods. Muneer Mohammad Bustanji (1) Sawsan Majali (2)

American Journal of Oral Medicine and Radiology

The Clinical Debates

Faculty of Health Sciences Outcomes of campaigns for Palestine refugees with diabetes mellitus attending UNRWA health centers

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES

ANNUAL HEALTH CHECKUP BASIC HEALTH PACKAGE

Methods. Background and Objectives STRADIVARIUS

Abstract. (Left Mouse-click to begin and move to next slide.)

Health Indicators and Status in the European Union

Adiponectin, TG/HDL-cholesterol index and hs-crp. Predictors of insulin resistance.

Transcription:

PERCEPTION OF CVD RISK FACTORS BY DIFFERENT STAKEHOLDERS - DOCTORS, MEDICAL STUDENTS, GENERAL PUBLIC, POLITICIANS, JOURNALISTS Professor ŽeljkoReiner, MD,PhD,FRCP(Lond),FESC,FACC University Hospital Center Zagreb, University of Zagreb, Zagreb School of Medicine, Croatia

CAUSES OF DEATH IN CROATIA IN 2008 Izvor podataka: Državni zavod za statistiku, Hrvatski zavod za javno zdravstvo

PERCRO Study - PERCEPTION OF CARDIOVASCULAR RISK FACTORS IN CROATIA GENERAL POPULATION A questionnaire with 25 multiple choice questions In 37 pharmacies covering the whole area of Croatia consecutively to all customers willing to answer 883 respondents (questionnaires finished) September 1 to November 30, 2007

PERCRO Study - PERCEPTION OF CARDIOVASCULAR RISK FACTORS IN CROATIA PHYSICIANS In Croatia - 11 799 physicians (1753 GPs and 927 specialists in GP/family medicine, 987 general internists, 203 cardiologists) randomly recruited using national physicians registry and professional societies directories 5 regions, all cardiologists, every third GP/FP, every fifth internist A questionnaire with 25 multiple choice questions 1382 physicians (930 GP/FP, 165 cardiologists, 213 internists) answered March 1 to June 30, 2008

PERCRO Study - PERCEPTION OF CARDIOVASCULAR RISK FACTORS IN CROATIA MEDICAL STUDENTS A questionnaire with 25 multiple choice questions 443 medical students at the beginning of the study and at the end of the study On the enrolment day and graduation day September 2008 School of Medicine, University of Zagreb

PERCRO Study - PERCEPTION OF CARDIOVASCULAR RISK FACTORS IN CROATIA MEMBERS OF PARLIAMENT 77 out of 141 members of the Croatian Parliament - Sabor One day during the Parliament session in the Houses of Parliament 2008 A questionnaire with 25 multiple choice questions

PERCRO Study - PERCEPTION OF CARDIOVASCULAR RISK FACTORS IN CROATIA JOURNALISTS A questionnaire with 25 multiple choice questions 129 journalists from daily press newspaper, TV, radio In the Croatian Press Association House One day in 2008

Age Groups Distribution (years) 46,9% 35,9% 31,5% 24,0% 26,2% 28,8% 27,1% 27,1% 22,8% 19,0% 23,3% 23,9% General Pupolation Journalists Politicians Doctors 16,3% 7,9% 1,6% 1,1% 0% 0% 0% 0% 5,4% 6,8% 8,7% 3,9% 9,6% 2,2% 0% 0% 0% 0% 0% 0% 15-24 25-34 35-44 45-54 55-64 65-74 75-84 >85 Medical Students all belong to the 15-24 age group

Groups by Gender General Population Journalists 47% 53% 44% 56% Medical Students Politicians 67,42% 32,58% 59,72% 40,28% Male Female

Knowledge of Blood Pressure General Population Journalists 13% 26% 74% 87% Know Their Blood Pressure Don't know/no Answer Medical Students Politicians 18% 82% 10% 90%

Knowledge of Cholesterol Levels General Population Journalists 58% 42% 57% 43% Know Their Level Don't Know Level/No Answer Medical Students Politicians 26% 21% 74% 79%

Awareness of Bad Cholesterol 83,5% 56,8% 54,3% General Population Journalists Medical Students Politicians 31,0% 14,7% 10,9% 9,9% 12,0% 5,3% 26,4% 27,3% 20,2% 14,1% 8,7% 7,8% 5,3% 5,3% 2,7% 2,0% 1,8% HDL Cholesterol LDL Cholesterol Triglycerides None of Mentioned No Answer/Invalid Answer

Awareness of Good Cholesterol 82,4% 62,3% Population Journalists Medical Students Politicians 45,0% 50,0% 23,9% 26,4% 26,0% 16,3% 12,0% 9,8% 5,2% 2,2% 3,1% 0,9% 1,3% 14,1% 9,3% 5,2% 2,5% 2,3% HDL Cholesterol LDL Cholesterol Triglycerides None of Mentioned No Answer/Invalid Answer

Fear of Listed Diseases 63,9% 40,0% 48,6% 42,9% General Population Journalists Medical Students Politicians 28,6% 14,3% 14,5% 18,6% 10,4% 13,5% 13,0% 5,1% 0% 21,6% 23,3% 16,5% 9,3% 7,0% 0,0% 2,0% 2,3% 0% 0,0% 0,2% 0,8% 1,1% 1,3% 1,8% Cancer Cerebrovascular disease AIDS Heart disease Liver disease Tuberculosis and pulmonary disease No Answer/ Don'tknow

Awareness of the Leading Cause of Death Traffic Accidents Cancer 6,2% 10,8% 6,2% 10,5% 10,6% 16,3% 16,3% 27,0% Politicians Medical Students Journalists Population Cerebrovascular Disease 5,4% 5,9% 5,4% 8,6% AIDS 0,0% 0,2% 0,0% 0,8% Heart Disease 36,1% 53,5% 53,5% 72,0% Liver Cirrhosis Tuberculosis/Pulmonary Disease Don't Know/No Answer 0,0% 0,2% 0,0% 0,3% 0,0% 0,0% 0,8% 0,2% 0,2% 17,7% 17,8% 16,4%

Total cholesterol p=0,764 Kruskal-Wallis test

Triglycerides p=0,767 Kruskal-Wallis test

HDL - cholesterol Population : Parliament p=0,540 Population : Journalists p=0,003 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing

LDL - cholesterol Population : Parliament p=0,999 Population : Journalists p=0,027 Journalists : Parliament p=0,045 Mann-Whitney test with correction for multiple testing

hs-crp Population : Parliament p=0,999 Population : Journalists p=0,069 Journalists : Parliament p=0,042 Mann-Whitney test with correction for multiple testing

Glucose Population : Parliament p=0,999 Population : Journalists p=0,015 Journalists : Parliament p=0,100 Mann-Whitney test with correction for multiple testing

HbA1c Population : Parliament p=0,876 Population : Journalists p=0,003 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing

Height Population : Parliament p=0,003 Population : Journalists p=0,390 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing

Weight Population : Parliament p=0,003 Population : Journalists p=0,999 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing

BMI Population : Parliament p=0,003 Population : Journalists p=0,681 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing

Waist Population : Parliament p=0,003 Population : Journalists p=0,999 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing

Smoking Habits 75% 79% 57% 52% General Population Journalists Medical Students 28% 30% Politicians 22% 18% 15% 18% 3% 3% Smoker Former smoker Non-smoker

GP informed about the CV risks High Cholesterol Levels 30,9% 44,1% High Blood Pressure 27,0% 42,6% Smoking 20,6% 22,0% Obesity/Overweight 14,7% 21,1% None 38,2% 52,8% Population Journalists

Doctors by Speciality 18,8% 3,0% 12,2% 68,9% Family Doctors Cardiologists Internists Neurologists

Following of CVD Prevention Guidelines by Speciality International Atherosclerosis Society guidelines 9,3% 18,4% 16,7% US Guidelines 1,9% 1,4% 1,4% Joint European guidelines from 2007 Joint European guidelines from 1998 9,3% 7,1% 3,8% 59,6% 59,1% 71,3% Cardiologists Internists Primary care Institution guidelines 0,9% 2,8% 1,4% Own judgment 7,4% 10,6% 17,5%

Guidelines usefulness Do not know guidelines 1,8% 1,2% 1,2% Not useful Fairly useful 0,5% 0,6% 0,3% 20,9% 15,4% 22,9% Cardiologists Internists Primary care Very useful 76,8% 82,7% 75,5%

Knowledge of Joint European guidelines recommendation for HDL-chol. in women < 1.2 mmol/l 3,8% 2,5% 6,3% > 1.2 mmol/l 59,2% 58,7% 69,7% < 1.0 mmol/l > 1.0 mmol/l 2,5% 7,0% 6,5% 23,6% 17,4% 21,0% Cardiologists Internists Primary care > 0.9 mmol/l 5,1% 3,0% 3,6% < 0.9 mmol/l 5,7% 0,5% 3,9%

Knowledge of Joint European CVD Prevention Guidelines recommendation for blood pressure in high risk patients 120/80 mmhg 38,2% 34,5% 50,5% 130/85 mmhg 39,7% 43,3% 48,5% Cardiologists Internists 150/90 mmhg 8,9% 17,8% 14,1% Primary care 140/90 mmhg 0,6% 2,9% 0,9%

Knowledge on optimal blood pressure in high risk patients 37,1% 42,1% 40,0% 45,2% Medical Students Doctors 15,7% 11,2% 6,3% 1,6% <150/90 <140/90 <130/85 <120/80

Knowledge of recommended HDLcholesterol in women (mmol/l) 60,2% 34,7% Medical Students Doctors 22,2% 21,1% 14,7% 3,7% 3,6% 3,9% 13,5% 5,9% 11,2% 5,3% <0,9 >0,9 >1,0 <1,0 >1,2 <1,2

Knowledge on recommended LDL-cholesterol in patients with diabetes (mmol/l) 56,1% 24,3% 20,5% 30,4% 30,0% 24,8% Medical Students Doctors 7,5% 6,4% <5 <4 <3 <2,5

Lowering cholesterol with diet 68,4% 54,5% Medical Student Doctors 26,7% 18,9% 11,9% 9,7% 5,0% 2,7% 1,9% 0,3% 2-3% 10-15% about 50% 50-70% up to 90%

Broj ispitanika (%) Do you Believe you Treat Well Your Patients with Hyperlipidemia? Sm atrate li da dobro liječite svoje bolesnike hipelipidem ijom 100 95 90 80 74 70 60 50 40 30 20 10 0 Liječnici OM (N=556) Kardiolozi (N=134) 19 7 4 1 da ne ne znam

Thank you!